CLINICAL_TRIALS
trial_result
· 2012-04-17
Clinical Trial Update: A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder [Phase 4]
Summary
Phase 4 trial update evaluating duloxetine dosing strategies in Korean patients with major depressive disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder (MDD) | Phase 4 | Status: COMPLETED | Results posted: 2012-04-17